ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Australian State/Territory : NSW
Scheme : ARC Future Fellowships
Research Topic : cancer/cachexia
Clear All
Filter by Field of Research
Cancer Cell Biology (5)
Oncology and Carcinogenesis (5)
Cancer Genetics (2)
Molecular Targets (2)
Biochemistry and Cell Biology (1)
Bioinformatics (1)
Biomaterials (1)
Cancer Therapy (excl. Chemotherapy and Radiation Therapy) (1)
Gene Expression (incl. Microarray and other genome-wide approaches) (1)
Haematological Tumours (1)
Macromolecular Chemistry Not Elsewhere Classified (1)
Macromolecular and Materials Chemistry (1)
Medical Biochemistry and Metabolomics (1)
Medical Biochemistry: Amino Acids and Metabolites (1)
Neurology and Neuromuscular Diseases (1)
Receptors and Membrane Biology (1)
Signal Transduction (1)
Synthesis Of Macromolecules (1)
Filter by Socio-Economic Objective
Cancer and Related Disorders (7)
Expanding Knowledge in the Biological Sciences (2)
Application Software Packages (excl. Computer Games) (1)
Cancer and related disorders (1)
Endocrine Organs and Diseases (excl. Diabetes) (1)
Expanding Knowledge in Technology (1)
Expanding Knowledge in the Medical and Health Sciences (1)
Nervous System and Disorders (1)
Polymeric materials (e.g. paints) (1)
Filter by Funding Provider
Australian Research Council (8)
Filter by Status
Closed (8)
Filter by Scheme
ARC Future Fellowships (8)
Filter by Country
Australia (8)
Filter by Australian State/Territory
NSW (8)
  • Researchers (12)
  • Funded Activities (8)
  • Organisations (16)
  • Funded Activity

    ARC Future Fellowships - Grant ID: FT130101289

    Funder
    Australian Research Council
    Funding Amount
    $749,814.00
    Summary
    mTOR signalling in serous ovarian cancer. Serous ovarian cancer is the most aggressive and lethal gynaecological cancer in Australian women. Activation of Mammalian Target of Rapamycin (mTOR) is frequently observed and associated with poor prognosis in ovarian cancer patients. However, the mechanisms dysregulating mTOR in the pathogenesis of ovarian cancer are unknown. In preliminary studies, deletion of genes regulating mTOR signalling in up to 60 per cent of human serous ovarian cancer patien .... mTOR signalling in serous ovarian cancer. Serous ovarian cancer is the most aggressive and lethal gynaecological cancer in Australian women. Activation of Mammalian Target of Rapamycin (mTOR) is frequently observed and associated with poor prognosis in ovarian cancer patients. However, the mechanisms dysregulating mTOR in the pathogenesis of ovarian cancer are unknown. In preliminary studies, deletion of genes regulating mTOR signalling in up to 60 per cent of human serous ovarian cancer patients was observed. This project will provide mechanistic details of involvement of mTOR signalling in pathogenesis of the serous ovarian carcinoma, and develop a rationale for targeting mTOR pathway in these patients.
    Read more Read less
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT120100323

    Funder
    Australian Research Council
    Funding Amount
    $697,088.00
    Summary
    The critical role of the class III histone deacetylase SIRT2 in stabilizing N-Myc oncoprotein. Cancer is the commonest cause of death from disease in children. Neuroblastoma is the commonest solid tumor in early childhood. This project will investigate the critical roles of SIRT2 protein in increasing the expression of N-Myc oncoprotein and consequently inducing neuroblastoma, and SIRT2 inhibitors as anticancer agents.
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT120100612

    Funder
    Australian Research Council
    Funding Amount
    $714,388.00
    Summary
    Identification of novel therapeutic targets for selectively eliminating cancer stem cells in paediatric leukaemia. Leukaemia is the most common form of cancer in children, and while the majority of children can be cured, those who relapse face a dire prognosis. It is widely believed that leukemic stem cells are responsible for relapse and this project will aim to unravel their underlying biology and identify new targets for therapeutic approaches to the disease.
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT100100489

    Funder
    Australian Research Council
    Funding Amount
    $813,192.00
    Summary
    Understanding endocrine tumorigenesis - opportunities for new diagnostics and therapies. This project will generate new knowledge significant for improving cancer diagnosis and designing new therapies for cancer patients as we embrace the personalised medicine era. Specific focus is on endocrine tumours. This research has as its aim improved survival for people diagnosed with cancer.
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT120100880

    Funder
    Australian Research Council
    Funding Amount
    $714,528.00
    Summary
    Determination of cellular mechanisms underpinning cancer cell metastasis through integrated in vivo imaging approaches. Understanding key steps that drive the spread of cancer is critical to improve current treatment strategies. Using cutting-edge imaging technology and in vivo model systems that mimic the disease, this project will pinpoint key events that are susceptible to drug intervention and identify new therapeutic targets.
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT0991273

    Funder
    Australian Research Council
    Funding Amount
    $788,800.00
    Summary
    Platinum drugs containing core-shell nanoparticles. Many drugs such as cancer drugs contain metal ions. While the therapeutic benefits of metal containing drugs are highly promising, their administration is often accompanied by substantial side effects. Encapsulation of these drugs into nano-sized core-shell particles will prolong the circulation of the drug and therefore reduce the amount of repeated administrations. In addition, the shape and nature of the particle will enable the targeted del .... Platinum drugs containing core-shell nanoparticles. Many drugs such as cancer drugs contain metal ions. While the therapeutic benefits of metal containing drugs are highly promising, their administration is often accompanied by substantial side effects. Encapsulation of these drugs into nano-sized core-shell particles will prolong the circulation of the drug and therefore reduce the amount of repeated administrations. In addition, the shape and nature of the particle will enable the targeted delivery of these drug loaded nanocarriers to the tumor while healthy tissue remains unaffected.
    Read more Read less
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT120100397

    Funder
    Australian Research Council
    Funding Amount
    $818,856.00
    Summary
    Roles of the kynurenine pathway in physiological and pathological brain function. This project will aim to study the metabolism of the essential amino acid tryptophan in the brain and its involvement in diseases including multiple sclerosis and brain tumours.
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT130100096

    Funder
    Australian Research Council
    Funding Amount
    $705,585.00
    Summary
    Exploring novel coding genomic features through integrative proteogenomics. Knowledge of the full extent to which the human genome is made into proteins is of fundamental importance in the study of health and disease. New technological advances are now enabling functional studies of genomes with increasing detail. This project aims to develop and apply cutting edge bioinformatics methods to perform an integrative and comprehensive exploration of the extent to which the genes of a human cell line .... Exploring novel coding genomic features through integrative proteogenomics. Knowledge of the full extent to which the human genome is made into proteins is of fundamental importance in the study of health and disease. New technological advances are now enabling functional studies of genomes with increasing detail. This project aims to develop and apply cutting edge bioinformatics methods to perform an integrative and comprehensive exploration of the extent to which the genes of a human cell line are made into proteins. The project will improve our understanding of the human genome and deliver cutting edge methodology applicable for genome annotation in all living organisms.
    Read more Read less
    More information

    Showing 1-8 of 8 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback